Springe direkt zu Inhalt

Talks (selected)

  • Advances and challenges of inflammatory skin disease models. BB3R - Rethinking Biomedical Sciences, Scientific 3R Symposium, Berlin / Germany, 2 October 2018
  • Pharmacological targeting of the first barrier of the immune response. International Conference on Contemporary Science and Clinical Pharmacy (ICCSCP) 2018, Padang / Indonesia, 6 July 2018
  • Novel modes of action for synthetic anti-lipopolysaccharide peptides: Inhibition of inflammasome activation and promotion of wound healing. 2018 Glycolipid Meeting Structures, functions, and interactions of Membrane Compounds, Hamburg / Germany, 1 June 2018
  • Immunocompetent Skin Models? BB3R Spring School 2018 – Alternatives to Animal Testing, Berlin / Germany, 12 April 2018
  • Pep19-2.5 accelerates wound healing in vivo. 2017 Glycolipid Meeting - Structures, functions, and interactions of Membrane Compounds, Hamburg / Germany, 2 June 2017
  • New pharmacological insights on the anti-inflammatory potential of sphingosine-1-phosphate (in German). 21st Annual Meeting of the Society for Dermopharmacy, Munich / Germany, 21 March 2017
  • In vitro human tissue models for infectious and inflammatory skin diseases. Research seminar Charité, Klinik für Dermatologie, Venerologie und Allergologie, Berlin / Germany, 18 April 2016
  • In vitro reconstituted human epithelia for inflammatory and infectious diseases. SFB 1112 Colloqium, Berlin / Germany, 7 January 2016
  • Functional characterization of reconstructed skin containing in vitro generated Langerhans cells. EUSAAT 2015 - 16th Annual Congress of EUSAAT / Linz 2015 - 19th European Congress on Alternatives to Animal Testing, Linz / Austria, 22 September 2015
  • Skin models in pharmacology and toxicology - opportunities and potential limitations of alternative methods (in German). Goethe University Frankfurt, Campus Riedberg, Frankfurt am Main / Germany, 24 June 2015
  • Pep19-2.5 and Pep19-4LF suppress inflammatory and immune responses in skin cells. 2016 Glycolipid Meeting - Structures, functions, and interactions of Membrane Compounds, Satellite Meeting of the 14th Biennial Meeting of the International Endotoxin and Innate Immune Society, Hamburg / Germany, 21 September 2016
  • Evaluation of synthetic antimicrobial peptides for topical skin therapy. 2015 Glycolipid Meeting - Structures, functions, and interactions of Membrane Compounds, Hamburg / Germany, 5 June 2015
  • Human skin models for the characterisation of immunological processes - opportunities and limitations of alternative methods (in German). 19th Annual Meeting of the Society for Dermopharmacy, Berlin / Germany, 17 March 2015
  • Dendritic cells as regulators of skin inflammation (in German). Fortbildungskolloquium der Klinik und Poliklinik für Dermatologie und Allergologie der LMU München, Munich / Germany, 21 January 2015
  • Human skin models for the characterisation of xenobiotic biotransformation and immunological processes (in German). Life Science Seminar Beiersdorf AG, Hamburg / Germany, 21 August 2014
  • Taking care of your skin (in German). Summer University of the Freie Universität Berlin, Berlin / Germany, 19 August 2014
  • Langerhans cells as skin immune sentinels – shaping immune responses during inflammation. Heinz Maurer Symposium "Review and Preview in Science for Healthy Skin", Boppard / Germany, 28 June 2014
  • Infection models for localised candidosis - From molecular pathogenesis to testing of antifungal agents (in German). DPhG Vortragsprogramm Landesgruppe Niedersachsen / Untergruppe Braunschweig, Braunschweig / Germany, 22 May 2014
  • Antifungal agents - fundamentals and pharmaceutical aspects (in German). Fortbildungsveranstaltung der Apothekerkammer Berlin, Berlin / Germany, 22 January 2014
  • Reconstructed human skin as disease models. Symposium of GD Society for Dermopharmacy on "Dermatotoxicological and other Safety Testing Methods without Animlals - Status November 2013", Berlin / Germany, 28 November 2013
  • Reconstructed human skin as alternative test system in pharmacology. Universidade de São Paulo (USP), Faculdade de Ciências Farmacêuticas, São Paulo / Brazil, 22 November 2013
  • Reconstructed human skin as alternative test system in pharmacology. Universidade Estadual de Campinas (UNICAMP), Faculdade de Ciências Médicas, Campinas / Brazil, 21 November 2013
  • Phase I biotransformation of testosterone by human skin and reconstructed skin tissues.  EUSAAT 2013 - 15th Annual Congress of EUSAAT / Linz 2013 - 18th European Congress on Alternatives to Animal Testing / ESNATS Conference, Linz / Austria, 18 September 2013
  • Increased cutaneous absorption reflects impaired barrier function of reconstructed skin models mimicking keratinisation disorders.  EUSAAT 2013 - 15th Annual Congress of EUSAAT / Linz 2013 - 18th European Congress on Alternatives to Animal Testing / ESNATS Conference, Linz / Austria, 15 September 2013
  • Human skin models for skin infections and inflamed skin (in German). 17th Annual Meeting of the Society for Dermopharmacy, Mainz / Germany, 22 March 2013
  • In vitro human tissue models for infectious and inflammatory skin diseases. European Society of Toxicology in Vitro 2012 International Conference (ESTIV2012), Lisbon / Portugal, 17 October 2012
  • Characterization of reconstructed human skin following topical treatment with glucocorticoid creams. EUSAAT 2012 - 14th Annual Congress of EUSAAT / Linz 2012 - 17th European Congress on Alternatives to Animal Testing, Linz / Austria, 07 September 2012
  • Esterase Activity in Excised and Reconstructed Human Skin - Biotransformation of Prednicarbate and the Model Dye Fluorescein Diacetate. EUSAAT 2012 - 14th Annual Congress of EUSAAT / Linz 2012 - 17th European Congress on Alternatives to Animal Testing, Linz / Austria, 06 September 2012
  • Glucocorticoids for the skin (in German). DPhG Vortragsprogramm Landesgruppe Berlin-Brandenburg, Berlin / Germany, 26 April 2012
  • Glucocorticoids on the skin (in German). 86. Zentrale Fortbildungsveranstaltung der Landesapothekerkammer Hessen, Gießen / Germany, 17 March 2012
  • Modulation of Proinflammatory Responses in Human Skin Cells by Cross-Talk between TLR and S1P Signalling. 2011 ESDR Academy for Future Leaders in Dermatology, Cascais / Portugal, 11 November 2011
  • Organisation of the symposium of the section "Pharmacology and Toxicology" of the German Pharmaceutical Society „In vitro skin models as alternative pharmacological test systems“ and talk "In vitro infection models for localised candidosis" (in German). Annual Meeting of the German Pharmaceutical Society, Braunschweig / Germany, 06 October 2010
  • Comparative analysis of esterase activity in reconstructed human skin models and excised human skin. Jahrestagung der Deutschen Pharmazeutischen Gesellschaft, Braunschweig / Germany, 05 October 2010
  • Models of localized Candida infections based on in vitro reconstituted human epithelia. ESTIV 2010 - the 16th International Congress on In Vitro Toxicology / EUSAAT 2010 - 13th Annual Congress of EUSAAT / Linz 2010 - 16th Congress on Alternatives to Animal Testing, Linz / Austria, 02 September 2010
  • In vitro infection models of localized Candida infections. Skin in Vitro 2010 Symposium, Frankfurt a. Main / Germany, 08 June 2010
  • In vitro infection models for localised candidosis (in German). 14th Annual Meeting of the Society for Dermopharmacy, Berlin / Germany, 24 March 2010
  • Toll-like receptors - new targets for dermatotherapy (in German). 14th Annual Meeting of the Society for Dermopharmacy, Berlin / Germany, 23 March 2010
  • Polymerase alpha Inhibition – from Molecular Modelling to Nanotechnology in Human Skin Cancer Therapy. Makassar International Symposium on Pharmaceutical Science 2009 - Recent Progress in Drug Discovery, Makassar / Indonesia, 19-20 March 2009